<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38773966</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1838-7640</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Theranostics</Title><ISOAbbreviation>Theranostics</ISOAbbreviation></Journal><ArticleTitle>Hyperglycemia facilitates EV71 replication: Insights into miR-206-mediated regulation of G3BP2 promoting EV71 IRES activity.</ArticleTitle><Pagination><StartPage>2706</StartPage><EndPage>2718</EndPage><MedlinePgn>2706-2718</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7150/thno.93883</ELocationID><Abstract><AbstractText><b>Background:</b> Neurotropic virus infections actively manipulate host cell metabolism to enhance virus neurovirulence. Although hyperglycemia is common during severe infections, its specific role remains unclear. This study investigates the impact of hyperglycemia on the neurovirulence of enterovirus 71 (EV71), a neurovirulent virus relying on internal ribosome entry site (IRES)-mediated translation for replication. <b>Methods:</b> Utilizing hSCARB2-transgenic mice, we explore the effects of hyperglycemia in EV71 infection and elucidate the underlying mechanisms. <b>Results:</b> Remarkably, administering insulin alone to reduce hyperglycemia in hSCARB2-transgenic mice results in a decrease in brainstem encephalitis and viral load. Conversely, induced hyperglycemia exacerbates neuropathogenesis, highlighting the pivotal role of hyperglycemia in neurovirulence. Notably, miR-206 emerges as a crucial mediator induced by viral infection, with its expression further heightened by hyperglycemia and concurrently repressed by insulin. The use of antagomiR-206 effectively mitigates EV71-induced brainstem encephalitis and reduces viral load. Mechanistically, miR-206 facilitates IRES-driven virus replication by repressing the stress granule protein G3BP2. <b>Conclusions:</b> Novel therapeutic approaches against severe EV71 infections involve managing hyperglycemia and targeting the miR-206-stress granule pathway to modulate virus IRES activity.</AbstractText><CopyrightInformation>© The author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Rai-Hua</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>National Center for Geriatrics and Welfare Research, National Health Research Institutes, Miaoli, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Yen-Hung</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yi-Wen</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Nai-Hsiang</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nien</LastName><ForeName>Shu-Wei</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microarray Core Laboratory, National Health Research Institutes, Miaoli, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juang</LastName><ForeName>Jyh-Lyh</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Theranostics</MedlineTA><NlmUniqueID>101552395</NlmUniqueID><ISSNLinking>1838-7640</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067556">Internal Ribosome Entry Sites</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C540669">Mirn206 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="Y">Hyperglycemia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067556" MajorTopicYN="Y">Internal Ribosome Entry Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">hyperglycemia</Keyword><Keyword MajorTopicYN="N">internal ribosome entry site (IRES)</Keyword><Keyword MajorTopicYN="N">miR-206</Keyword><Keyword MajorTopicYN="N">neurovirulence</Keyword></KeywordList><CoiStatement>Competing Interests: The authors have declared that no competing interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>3</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38773966</ArticleId><ArticleId IdType="pmc">PMC11103504</ArticleId><ArticleId IdType="doi">10.7150/thno.93883</ArticleId><ArticleId IdType="pii">thnov14p2706</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen BS, Lee HC, Lee KM, Gong YN, Shih SR. Enterovirus and Encephalitis. Front Microbiol. 2020;11:261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7044131</ArticleId><ArticleId IdType="pubmed">32153545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohka S, Nihei C, Yamazaki M, Nomoto A. Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway. Front Microbiol. 2012;3:147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328850</ArticleId><ArticleId IdType="pubmed">22529845</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik JA, Ahmed S, Mir A, Shinde M, Bender O, Alshammari F. et al. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges. J Infect Public Health. 2022;15:228–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8730674</ArticleId><ArticleId IdType="pubmed">35042059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai RH, Chow YH, Chung NH, Chen TC, Shie FS, Juang JL. Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signaling. Cell Death Dis. 2022;13:328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8995170</ArticleId><ArticleId IdType="pubmed">35399111</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu GH, Lee KM, Kao CY, Shih SR. The internal ribosome entry site determines the neurotropic potential of enterovirus A71. Microbes Infect. 2023;25:105107.</Citation><ArticleIdList><ArticleId IdType="pubmed">36708870</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston C, Jiang W, Chu T, Levine B. Identification of genes involved in the host response to neurovirulent alphavirus infection. J Virol. 2001;75:10431–45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114617</ArticleId><ArticleId IdType="pubmed">11581411</ArticleId></ArticleIdList></Reference><Reference><Citation>Paludan SR, Pradeu T, Masters SL, Mogensen TH. Constitutive immune mechanisms: mediators of host defence and immune regulation. Nat Rev Immunol. 2021;21:137–50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418297</ArticleId><ArticleId IdType="pubmed">32782357</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY. Enterovirus 71 in Taiwan. Pediatr Neonatol. 2008;49:103–12.</Citation><ArticleIdList><ArticleId IdType="pubmed">19054914</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91–107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-Or D, Rael LT, Madayag RM, Banton KL, Tanner A 2nd, Acuna DL. et al. Stress Hyperglycemia in Critically Ill Patients: Insight Into Possible Molecular Pathways. Front Med (Lausanne) 2019;6:54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6445875</ArticleId><ArticleId IdType="pubmed">30972338</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F. et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17065355</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondel B, Colbere-Garapin F, Couderc T, Wirotius A, Guivel-Benhassine F. Poliovirus, pathogenesis of poliomyelitis, and apoptosis. Curr Top Microbiol Immunol. 2005;289:25–56.</Citation><ArticleIdList><ArticleId IdType="pubmed">15791950</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromeier M, Alexander L, Wimmer E. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc Natl Acad Sci U S A. 1996;93:2370–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC39803</ArticleId><ArticleId IdType="pubmed">8637880</ArticleId></ArticleIdList></Reference><Reference><Citation>Gradi A, Svitkin YV, Imataka H, Sonenberg N. Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc Natl Acad Sci U S A. 1998;95:11089–94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21600</ArticleId><ArticleId IdType="pubmed">9736694</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KM, Chen CJ, Shih SR. Regulation Mechanisms of Viral IRES-Driven Translation. Trends Microbiol. 2017;25:546–61.</Citation><ArticleIdList><ArticleId IdType="pubmed">28242053</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, Morgan NG. Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention. Curr Opin Pharmacol. 2018;43:11–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6294842</ArticleId><ArticleId IdType="pubmed">30064099</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YF, Deng HL, Fu J, Zhang Y, Wei JQ. Pancreatitis in hand-foot-and-mouth disease caused by enterovirus 71. World J Gastroenterol. 2016;22:2149–52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4726688</ArticleId><ArticleId IdType="pubmed">26877620</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T. et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15:798–801.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Yu SL, Shao HY, Lin HY, Liu CC, Hsiao KN. et al. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS One. 2013;8:e57591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschinsky FM, Wilson DF. The Central Role of Glucokinase in Glucose Homeostasis: A Perspective 50 Years After Demonstrating the Presence of the Enzyme in Islets of Langerhans. Front Physiol. 2019;10:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6435959</ArticleId><ArticleId IdType="pubmed">30949058</ArticleId></ArticleIdList></Reference><Reference><Citation>Malka D, Vasseur S, Bodeker H, Ortiz EM, Dusetti NJ, Verrando P. et al. Tumor necrosis factor alpha triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation. Gastroenterology. 2000;119:816–28.</Citation><ArticleIdList><ArticleId IdType="pubmed">10982776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez J, Jackson I, Flaherty KR, Muliaditan T, Schurich A. Divergent Impact of Glucose Availability on Human Virus-Specific and Generically Activated CD8 T Cells. Metabolites. 2020. 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7696163</ArticleId><ArticleId IdType="pubmed">33202938</ArticleId></ArticleIdList></Reference><Reference><Citation>Raber J, Rhea EM, Banks WA. The Effects of Viruses on Insulin Sensitivity and Blood-Brain Barrier Function. Int J Mol Sci. 2023. 24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917142</ArticleId><ArticleId IdType="pubmed">36768699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho BC, Yu IS, Lu LF, Rudensky A, Chen HY, Tsai CW. et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun. 2014;5:3344.</Citation><ArticleIdList><ArticleId IdType="pubmed">24561744</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalsky RL, Cullen BR. Viruses, microRNAs, and host interactions. Annu Rev Microbiol. 2010;64:123–41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3621958</ArticleId><ArticleId IdType="pubmed">20477536</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinod M, Patankar JV, Sachdev V, Frank S, Graier WF, Kratky D. et al. MiR-206 is expressed in pancreatic islets and regulates glucokinase activity. Am J Physiol Endocrinol Metab. 2016;311:E175–E85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941929</ArticleId><ArticleId IdType="pubmed">27221121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Zhang T, Pan F, Steer CJ, Li Z, Chen X. et al. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis. J Hepatol. 2017;66:816–24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5568011</ArticleId><ArticleId IdType="pubmed">28025059</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin G, Zhang Z, Wan J, Wu X, Liu X, Zhang W. G3BP2: Structure and function. Pharmacol Res. 2022;186:106548.</Citation><ArticleIdList><ArticleId IdType="pubmed">36336216</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuki H, Takahashi M, Higuchi M, Makokha GN, Oie M, Fujii M. Both G3BP1 and G3BP2 contribute to stress granule formation. Genes Cells. 2013;18:135–46.</Citation><ArticleIdList><ArticleId IdType="pubmed">23279204</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser LJ, Medina GN, Rabouw HH, de Groot RJ, Langereis MA, de Los Santos T, Foot-and-Mouth Disease Virus Leader Protease Cleaves G3BP1 and G3BP2 and Inhibits Stress Granule Formation. J Virol. 2019. 93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6321903</ArticleId><ArticleId IdType="pubmed">30404792</ArticleId></ArticleIdList></Reference><Reference><Citation>Slaine PD, Kleer M, Smith NK, Khaperskyy DA, McCormick C. Stress Granule-Inducing Eukaryotic Translation Initiation Factor 4A Inhibitors Block Influenza A Virus Replication. Viruses. 2017. 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5744162</ArticleId><ArticleId IdType="pubmed">29258238</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey K, Zhong S, Diel DG, Hou Y, Wang Q, Nelson E. et al. GTPase-activating protein-binding protein 1 (G3BP1) plays an antiviral role against porcine epidemic diarrhea virus. Vet Microbiol. 2019;236:108392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7117524</ArticleId><ArticleId IdType="pubmed">31500725</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidet K, Dadlani D, Garcia-Blanco MA. G3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs and are targeted by a dengue virus non-coding RNA. PLoS Pathog. 2014;10:e1004242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4081823</ArticleId><ArticleId IdType="pubmed">24992036</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu M, Courtney SC, Brinton MA. Arsenite-induced stress granule formation is inhibited by elevated levels of reduced glutathione in West Nile virus-infected cells. PLoS Pathog. 2017;13:e1006240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5344523</ArticleId><ArticleId IdType="pubmed">28241074</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Bai Y, Zhang X, Gao T, Liu Y, Li E. et al. SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication. J Virol. 2022;96:e0041222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9215227</ArticleId><ArticleId IdType="pubmed">35652658</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis MD, Shenberger JS, Stanley BA, Kimball SR, Jefferson LS. Hyperglycemia mediates a shift from cap-dependent to cap-independent translation via a 4E-BP1-dependent mechanism. Diabetes. 2013;62:2204–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712054</ArticleId><ArticleId IdType="pubmed">23434932</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayabalan AK, Adivarahan S, Koppula A, Abraham R, Batish M, Zenklusen D, Stress granule formation, disassembly, and composition are regulated by alphavirus ADP-ribosylhydrolase activity. Proc Natl Acad Sci U S A. 2021. 118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8017970</ArticleId><ArticleId IdType="pubmed">33547245</ArticleId></ArticleIdList></Reference><Reference><Citation>Godet AC, David F, Hantelys F, Tatin F, Lacazette E, Garmy-Susini B, IRES Trans-Acting Factors, Key Actors of the Stress Response. Int J Mol Sci. 2019. 20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6412753</ArticleId><ArticleId IdType="pubmed">30791615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabekkodu SP, Shukla V, Varghese VK, J DS, Chakrabarty S, Satyamoorthy K. Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc. 2018;93:1955–86.</Citation><ArticleIdList><ArticleId IdType="pubmed">29797774</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan LJ. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. J Diabetes Res. 2014;2014:137919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4082845</ArticleId><ArticleId IdType="pubmed">25019091</ArticleId></ArticleIdList></Reference><Reference><Citation>Girdhar K, Powis A, Raisingani A, Chrudinova M, Huang R, Tran T. et al. Viruses and Metabolism: The Effects of Viral Infections and Viral Insulins on Host Metabolism. Annu Rev Virol. 2021;8:373–91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9175272</ArticleId><ArticleId IdType="pubmed">34586876</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez EL, Lagunoff M. Viral activation of cellular metabolism. Virology. 2015;479-480:609–18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4424078</ArticleId><ArticleId IdType="pubmed">25812764</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia KG, Feng G, Tong YS, Tao GZ, Xu L. miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2. J Biochem. 2020;167:365–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">31742336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge X, Lyu P, Cao Z, Li J, Guo G, Xia W. et al. Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting. Biochem Biophys Res Commun. 2015;463:1115–21.</Citation><ArticleIdList><ArticleId IdType="pubmed">26093295</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Wang XM, Wang Q, Yang M, Feng XC, Shen ZH. Down-regulation of N-acetylglucosaminyltransferase-V induces ER stress by changing glycosylation and function of GLUT1. Arch Biochem Biophys. 2007;463:102–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17451637</ArticleId></ArticleIdList></Reference><Reference><Citation>Jheng JR, Lau KS, Tang WF, Wu MS, Horng JT. Endoplasmic reticulum stress is induced and modulated by enterovirus 71. Cell Microbiol. 2010;12:796–813.</Citation><ArticleIdList><ArticleId IdType="pubmed">20070307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Zhang Y, Li H, Liu L. Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines. Int J Mol Sci. 2022. 24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9820767</ArticleId><ArticleId IdType="pubmed">36613612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragonnet-Cronin M, Nutalai R, Huo J, Dijokaite-Guraliuc A, Das R, Tuekprakhon A. et al. Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy. Nat Commun. 2023;14:3334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10246534</ArticleId><ArticleId IdType="pubmed">37286554</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>